Helping transplanted insulin-producing cells with engineered immune cells
Engineering T cells to Promote Islet Transplant
This project explores how specially designed immune cells can protect transplanted insulin-producing cells for people with Type 1 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11058498 on NIH RePORTER |
What this research studies
Type 1 diabetes happens when your body's immune system mistakenly attacks and destroys the cells that make insulin. While transplanting healthy insulin-producing cells (islets) can help, your body often tries to reject them, requiring strong medications to suppress your immune system. This project aims to create special immune cells that can specifically protect these transplanted islets from being attacked. The hope is that these engineered cells will allow successful transplants with fewer or no additional immune-suppressing drugs, offering a new path for treating Type 1 diabetes.
Who could benefit from this research
Good fit: This research is focused on individuals with Type 1 diabetes who might benefit from islet transplantation.
Not a fit: Patients whose Type 1 diabetes is well-managed with current insulin therapies or who are not candidates for islet transplantation may not directly benefit from this specific approach.
Why it matters
Potential benefit: If successful, this approach could make islet transplantation a safer and more effective treatment for Type 1 diabetes, potentially reducing the need for lifelong immunosuppression.
How similar studies have performed: While engineered T cells have shown success in treating other diseases like leukemia, this specific application to protect transplanted islets in Type 1 diabetes is a novel approach.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Riley, James L. — University of Pennsylvania
- Study coordinator: Riley, James L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.